Vol. 6 (01) pp. 36 DOI: 10.21474/IJAR01/6180

FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION.

  • University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.
19 Downloads 211 Views
Crossref

Keywords

Article Analytics

References

  1. Kee Y, D?Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia.J Clin Invest.2012;122:3799?3806.
  2. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia.?2002;297(5581):606?609.
  3. Alter BP. Cancer in Fanconi anemia, 1927-2001. 2003; 15;97:425-440.

How to Cite This Article

Alparslan Merdin. (2018); FANCONI ANEMIA: FUTURE NEEDS AND QUESTIONING THE DEFINITION., Int. J. of Adv. Res., 6 (01), 36, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6180

Corresponding Author

AlparslanMerdin
University of Health Sciences,Ankara Dr. Abdurrahman YurtaslanOncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.